Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference29 articles.
1. Contemporary issues in the care of patients with chronic obstructive pulmonary disease;Urbano;J Manag Care Pharm,2005
2. The epidemiology and economics of chronic obstructive pulmonary disease;Mannino;Proc Am Thorac Soc,2007
3. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline;Wilt;Ann Intern Med,2007
4. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations;Ferguson;Respir Med,2008
5. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease;Calverley;N Engl J Med,2007
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intraclass comparison of inhaled corticosteroids for the risk of pneumonia in chronic obstructive pulmonary airway disorder: a network meta-analysis and meta-regression;International Journal of Clinical Pharmacy;2024-04-25
2. Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK;International Journal of Chronic Obstructive Pulmonary Disease;2023-08
3. Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease;Therapeutic Advances in Respiratory Disease;2023-01
4. Different inhaled corticosteroid doses in triple therapy for chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis;Scientific Reports;2022-09-20
5. Efficacy of ICS versus Non-ICS Combination Therapy in COPD: A Meta-Analysis of Randomised Controlled Trials;International Journal of Chronic Obstructive Pulmonary Disease;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3